Chair and Director William C. Rupp, MD, is the former chief executive officer of the Mayo Clinic in Florida and a board certified physician with 32 years of experience in the fields of hematology and medical oncology. After graduating from the University of Minnesota Medical School, he completed his residency and fellowship at the University of Cincinnati Medical Center. Dr. Rupp served on the Board of Directors of Jacksonville University and recently completed a term as chair of the board of the Jacksonville Area Chamber of Commerce. He serves on the Finance and Patient Safety Committees at The Doctors Company.
Vice Chair and Director Robert M. Wachter, MD, is professor and chair of the Department of Medicine at the University of California, San Francisco, and a thought leader in organization of care, quality, patient safety, and digital health. Dr. Wachter, who has published more than 250 articles and six books, is the best-selling author of The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine’s Computer Age. He coined the term “hospitalist” in a 1996 New England Journal of Medicine article and is generally regarded as the academic leader of the hospitalist movement. Dr. Wachter is past president of the Society of Hospital Medicine. He is chair of the Patient Safety Committee and a member of the Technology Committee at The Doctors Company.
Treasurer/Secretary TC Wilson joined The Doctors Company as its first chief investment officer in 2017. Mr. Wilson is responsible for the development, management, and oversight of the company’s strategic investment program. He also ensures that overall investment and growth objectives are met in support of the company’s underwriting profile and operating results. He contributes to The Doctors Company’s strategic growth plan as it relates to investment review and assessment of new partnerships and opportunities. On a day-to-day basis, Mr. Wilson oversees the company’s investment portfolio with the goal of preserving and growing surplus. He also serves as chairman of The Doctors Company’s 401(k) Committee. Prior to joining The Doctors Company, Mr. Wilson served as head of Institutional Consulting for The Optimal Service Group (OSG), an investment consultant that specializes in investment advice to the medical malpractice industry. At OSG, he was the lead investment consultant to The Doctors Company from 2000 through 2017. Mr. Wilson has nearly 30 years of investment and consulting experience, including his initial five-year stint with one of the nation’s leading benefits consulting firms in Richmond, Virginia. He is a graduate of Hampden-Sydney College where he graduated Summa Cum Laude, earned Phi Beta Kappa honors, and was an Academic All-American for his success on the gridiron.
Director Richard E. Anderson, MD, FACP, is also the chairman and chief executive officer of The Doctors Company. Dr. Anderson was a clinical professor of Medicine at the University of California, San Diego, and is past chairman of the Department of Medicine at Scripps Memorial Hospital, where he served as senior oncologist for 18 years. Dr. Anderson currently serves as vice-chair for the MPL Association Education & Research Foundation, on the Board of Overseers of the RAND Institute for Civil Justice, and as a faculty member for the Institute for Healthcare Improvement (IHI). He serves on the Audit, Finance, Governance, Investment, Patient Safety, and Technology Committees at The Doctors Company.
Director James P. Bagian, MD, PE, is also the director of the Center for Healthcare Engineering and Patient Safety, as well as a professor in the Medical School and the College of Engineering at the University of Michigan. He is a diplomate of the American Board of Preventive Medicine and a member of the NASA Aerospace Safety Advisory Panel, National Academy of Engineering, and National Academy of Medicine. Dr. Bagian was a NASA astronaut for over 15 years and is a veteran of two Space Shuttle missions. Previously, he served as chairman of The Joint Commission’s Patient Safety Advisory Group and was the first and founding director of the National Center for Patient Safety and the first chief patient safety officer at the U.S. Department of Veterans Affairs. He is chair of the Technology Committee and a member of the Patient Safety Committee at The Doctors Company.
Director Daniel Kent Cassavar, MD, MBA, is the former president and chief medical officer of ProMedica Physicians, a healthcare network of specialized hospitals, facilities, researchers, physicians, and advanced practice providers. Prior to joining ProMedica Physicians, Dr. Cassavar was an interventional cardiologist with Heart Specialist of Northwest Ohio, a founding member of Cardiocare Consultants, and clinical assistant professor of Medicine in the Department of Internal Medicine at the Medical College of Ohio. He is a diplomate of the American Board of Internal Medicine (1992) and certified in Interventional Cardiology (2000) and Cardiovascular Diseases (1994). He is also a fellow of the American College of Physicians and the American College of Cardiology. Dr. Cassavar has published extensively and been the principal investigator on numerous clinical trials. He also serves on The Doctors Company Board of Governors and is a member of its Patient Safety Committee.
Director David L. Feldman, MD, MBA, CPE, FAAPL, FACS, is chief medical officer (CMO) of The Doctors Company Group. Dr. Feldman is also senior vice president and CMO at Healthcare Risk Advisors (HRA), formerly Hospitals Insurance Company and FOJP Service Corporation. Prior to HRA, Dr. Feldman was vice president for patient safety, vice president of perioperative services, and vice chairman of the department of surgery at Maimonides Medical Center in Brooklyn, New York. Dr. Feldman also serves on the steering committee of the American College of Surgeons (ACS) for retraining and retooling of practicing surgeons and has served on the ACS committee on perioperative care and as vice chairman of the ACS collaborative task force for the development of high-performance teams in surgery. He also served as the ACS liaison to the Association of periOperative Registered Nurses recommended practices committee.
Director Charles R. Kossman, PhD, MD, has 30 years of experience in the fields of hematology and medical oncology in Southern California. Dr. Kossman is a diplomate of the American Boards of Internal Medicine and Medical Oncology. He is clinical professor of Medicine at the University of California at San Diego. Dr. Kossman is chair of the Investment Committee and serves as a member of the Audit, Patient Safety, and Technology Committees at The Doctors Company.
Director Mary Ann Thode, JD, MPH, RN, is a healthcare executive with decades of experience leading top healthcare systems. Ms. Thode is the former president and CEO of the Northern California Region of Kaiser Foundation Health Plan and Hospitals. Prior to her 10 years with Kaiser, Ms. Thode served as a senior vice president of Operations for the Catholic Healthcare West System (CHW). She was previously the president and CEO of St. Mary's Medical Center, San Francisco, a division of CHW. Prior to joining The Doctors Company Board of Governors, Ms. Thode served on the Board of Directors of the California Hospital Association, the Bay Area Council, the American Cancer Society, the California State Chamber of Commerce, Mercy Housing Corporation, and Larkin Street Youth Services. She was also a member of the advisory board for the joint MPH/MBA program at the University of California, Berkeley. She serves as a member of the Audit, Compensation & Benefits, Investment, and Patient Safety Committees at The Doctors Company.
Executive Director Elizabeth Healy is also assistant vice president of Government and Community Relations at The Doctors Company. In more than 25 years in government relations, she has been involved in political campaigns and fundraising, grassroots organizing, state government, and legislative advocacy in the United States and the United Kingdom. Ms. Healy directs staff, lobbyists, and political action committees nationwide and in Washington, DC. She is also responsible for corporate charitable giving and community relations at The Doctors Company. She is currently on the Board of Directors for Californians Allied for Patient Protection, Coloradans Protecting Patient Access, the Civil Justice Association of California, and the Health Coalition on Liability and Access, among others. Ms. Healy also serves on the Board of Directors for the Community Health Initiative and on the Advisory Board for Mentis, Napa’s Center for Mental Health.
Deputy Director Susan Duke, MA, is also community relations specialist at The Doctors Company, where she manages corporate charitable giving and employee gift matching programs. She has a background in marketing, nonprofits, and community leadership, and more than a decade of experience in grantmaking, funder collaboration, and strengthening the impact of philanthropic efforts. Before joining The Doctors Company, she was senior manager of community investment with the Napa Valley Vintners, where she oversaw a portfolio of health, human services, and youth development grants.
Adviser Kerin Torpey Bashaw, MPH, RN, is also senior vice president of the Department of Patient Safety and Risk Management for The Doctors Company, where she is responsible for setting strategy across the nation for a team of nearly 50 patient safety experts. Ms. Bashaw has more than 25 years of experience in executive positions at top healthcare systems, including Verity Health System, Alameda Health System, Stanford Cancer Center, Stanford Health Care, and Kaiser Permanente. Her extensive background in patient safety, risk management, quality, accreditation, and operations supports continued progress by the Department of Patient Safety and Risk Management toward transforming data into actionable insights, providing industry-leading programs, enhancing quality, and delivering service and value to medical professionals in every practice model.
Counsel to the Foundation Devin O’Brien, Esq., is also deputy general counsel and vice president for The Doctors Company. Prior to joining The Doctors Company, Mr. O’Brien was in private practice, where his practice was devoted to litigation, primarily of professional liability claims and to coverage analysis and monitoring work for various insurers. Prior to attending law school, Mr. O’Brien worked on Capitol Hill for a prominent member of the California congressional delegation. He also served a secondment with the Beazley Syndicate and is active with the legal section of the MPL Association.